Amgen Inc (USD)
AMGN
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range249.52 | 252.73
52-Wk Range- | -
Last Close252.36
Mkt Cap (m)146,916.07
Dividend yield2.54
ISINUS0311621009
Volume1,431,498.00
Exchange VenueNAS

Company Profile

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.

Key Information
Price/Earning20.34
Price/Book13.40
Price/Sales5.99
P/CF13.79
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 06/05/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.amgen.com

Financials

Income Statement
USD201520162017201820192020
Revenue (m)21,662.0022,991.0022,849.0023,747.0023,362.00-
Operating Income (m)8,470.009,794.009,973.0010,263.009,674.00-
Net Income (m)6,939.007,722.001,979.008,394.007,842.00-
Basic EPS9.1510.322.7112.7012.96-
Avg. Diluted Shares Outstanding (m)766.00754.00735.00665.00609.00-
Balance Sheet
USD201520162017201820192020
Current Assets (m)38,518.0046,010.0049,476.0037,618.0018,440.00-
Non Current Assets (m)33,058.0031,616.0030,478.0028,798.0041,267.00-
Total Assets (m)71,576.0077,626.0079,954.0066,416.0059,707.00-
Current Liabilities (m)8,667.0011,204.009,020.0013,488.0012,835.00-
Total Liabilities (m)------
Total Equity (m)28,083.0029,875.0025,241.0012,500.009,673.00-
Cash Flows
USD201520162017201820192020
Operating Cash Flows (m)9,077.0010,354.0011,177.0011,296.009,150.00-
Capital Expenditure (m)-649.00-837.00-664.00-738.00-618.00-
Figures are quoted in USD unless stated otherwise
-0.87 (-0.34%)
$
251.50
Last Price